Pith. sign in

REVIEW 2 major objections 5 minor 17 references

Faithful by Design: Evaluating and Improving LLM-Generated Clinical Trial Summaries for Multi-Stakeholder Audiences

T0 review · 2 major / 5 minor · reviewed 2026-07-14 · grok-4.5

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read Knowledge-graph retrieval measurably raises faithfulness of LLM clinical-trial summaries, while unsupported claims remain the main failure mode.

desk verdict Useful multi-audience clinical-trial faithfulness benchmark and honest failure-mode diagnosis; KG-RAG NLI gains are real but small and sit on a proxy that misses the main clinical error type. read the letter →

arxiv 2607.09932 v1 pith:UEF42IBY submitted 2026-07-10 cs.CL cs.AI

Robert Williams This is my paper
classification cs.CLcs.AI
keywords clinicaltrialsummarizationfaithfulnessevaluationhallucinationdetectionknowledgegraphretrieval-augmentedgenerationNLIlargelanguagemodelsmulti-stakeholderaudiences
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Clinical trial results must be restated for providers, patients, and payers without inventing numbers, safety findings, or effects. Large language models can produce those summaries at scale, but they also invent material that is not in the source record. This paper builds a reusable benchmark of 200 stratified completed trials, three audience-specific prompt templates, and a six-dimension human faithfulness schema, then scores 1,800 model outputs with a sentence-level natural-language-inference metric. Across three leading models the dominant human-scored failure is unsupported claims (mean 1.55 out of 3). The authors then add a hybrid retrieval system that grounds each prompt in PubMed abstracts linked to the trial and re-ranked with a biomedical knowledge graph; the same NLI metrics rise by small but statistically reliable amounts (entailment +0.0125, faithfulness fraction +0.0130). The practical claim is that knowledge-graph-augmented retrieval is a usable control for improving faithfulness of high-stakes clinical summaries, even though automated metrics still miss the most clinically dangerous error type.

What carries the argument

KG-RAG: a retrieve-once-per-trial hybrid system that first ranks trial-linked PubMed abstracts by dense PubMedBERT similarity, then adds a fixed 0.15 boost for abstracts whose entities match the trial via the PubMed Knowledge Graph, and injects the top ten abstracts as non-authoritative background before the structured trial record.

What would settle it

A larger multi-annotator human study on the same 1,800 paired summaries that finds no reliable improvement on the Unsupported Claims dimension (or on overall human faithfulness) for KG-RAG versus baseline would falsify the practical claim that the retrieval intervention improves the clinically consequential form of faithfulness.

Watch

Extended reading notes

Core claim

Augmenting LLM prompts with hybrid retrieval over trial-linked PubMed abstracts and a PubMed knowledge-graph re-ranking signal produces statistically significant gains in cross-encoder NLI faithfulness scores (entailment_mean +0.0125, faithfulness_score +0.0130, p < 0.0001) across 1,800 paired summaries from GPT-4o, Claude Sonnet 4.6, and Gemini 2.5 Flash, while human annotation shows Unsupported Claims as the dominant baseline failure mode (mean 1.55/3).

Load-bearing premise

The main reported gains rest on the premise that sentence-level NLI scores against the trial record are a valid enough proxy for clinical faithfulness, even though they correlate only modestly with human ratings and almost not at all with the dominant unsupported-claims failures.

Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

2 major / 5 minor

Summary. The paper introduces a multi-stakeholder benchmark for faithfulness of LLM-generated clinical trial summaries: 200 stratified AACT trials (oncology, mental health, type 2 diabetes), three audience-specific prompts (providers, patients, payers), and a six-dimension ordinal annotation schema. Baselines for GPT-4o, Claude Sonnet 4.6, and Gemini 2.5 Flash (1,800 summaries) are scored with a DeBERTa-v3-small cross-encoder NLI model (trial record as premise). Human annotation of 51 pairs identifies Unsupported Claims as the dominant failure mode (mean 1.55/3). A hybrid KG-RAG system (PubMedBERT dense retrieval + PKG2020S4 concept boost) yields statistically significant NLI gains (entailment_mean +0.0125, faithfulness_score +0.0130, p < 0.0001 by Wilcoxon signed-rank on 1,800 pairs), with model-dependent pathways (GPT-4o via contradiction reduction; Claude/Gemini via entailment).

Significance. If the NLI gains track clinically meaningful faithfulness, the work supplies a reusable multi-audience evaluation scaffold and a practical KG-RAG intervention for high-stakes trial communication. Strengths include a stratified public benchmark, audience-specific prompts, open code, and a large paired NLI comparison with clear statistical testing. The explicit finding that Unsupported Claims is both dominant and nearly invisible to NLI is itself a useful negative result for the field. The clinical significance of the reported deltas, however, hinges on the validity of the automated proxy, which the paper itself shows is only modestly correlated with human scores and uncorrelated with the primary failure mode.

major comments (2)
  1. [§4.3, §5] §4.3 / §5: The central claim that KG-RAG improves faithfulness rests entirely on NLI deltas. The paper never re-annotates the 1,800 KG-RAG summaries on the six-dimension schema. Given that Unsupported Claims is the dominant baseline failure (mean 1.55; §4.1) and has near-zero Spearman correlation with entailment_mean (r = −0.058, p = 0.686; §4.2, Fig. 7), the clinical relevance of the NLI gains is untested. A modest paired re-annotation of KG-RAG vs. baseline outputs on at least Unsupported Claims (and preferably the full schema) is load-bearing for the claim that the intervention improves clinical faithfulness rather than only the NLI proxy.
  2. [§3.3–3.4, §4.2] §3.3–3.4 / §4.2: Human validation of the primary metric uses only 51 pairs scored by a single annotator. Composite correlation of entailment_mean with human scores is modest (r = +0.304, 95% CI roughly [+0.03, +0.53]), and the metric systematically fails on the dimension the paper identifies as most consequential. This sample size and single-annotator design underpower the claim that NLI is a sufficiently valid primary faithfulness metric for clinical trial summaries. At minimum, inter-annotator agreement and a larger validation set (or explicit framing of NLI as a directional screening tool only) are needed before the KG-RAG deltas can be treated as clinically interpretable.
minor comments (5)
  1. [§3.4] §3.4: The PKG concept-grounding boost (0.15), candidate pool (200), top-k (10), and abstract truncation (1,500 characters) are free hyperparameters with no sensitivity analysis. A brief ablation or justification would strengthen reproducibility claims.
  2. [§4.1] §4.1 / Fig. 3–5: Annotation results are reported only for baseline. Even a small qualitative comparison of KG-RAG vs. baseline on Unsupported Claims would help readers interpret the NLI gains.
  3. [§3.1, §5] §3.1: The 43.2% of abstracts outside PKG2020S4’s December 2020 window is correctly noted as a limitation; quantifying how often the concept boost is zero for the 200-trial benchmark would make the coverage ceiling more concrete.
  4. [§4.2–4.3] Figures 6–8: Violin and bar plots would benefit from explicit sample sizes and error bars (or CI) on the model-level means so readers can judge practical magnitude of the +0.0125 entailment shift.
  5. [§2, §3.2] References and related work are appropriate; a brief note on how the six-dimension schema relates to CONSORT and existing medical hallucination taxonomies (beyond the citations already present) would improve positioning.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: empirical NLI comparison of baseline vs KG-RAG on external AACT/PubMed/PKG data with an off-the-shelf cross-encoder; nothing is forced by construction or self-citation.

full rationale

The paper’s load-bearing claims are empirical measurements, not derivations. The 200-trial benchmark is stratified from the external AACT registry; the retrieval corpus is external PubMed abstracts linked by AACT study references; the concept layer is the external PKG2020S4 snapshot of Xu et al.; summaries are generated by three commercial LLMs under fixed zero-temperature prompts; and faithfulness is scored by an off-the-shelf DeBERTa-v3-small cross-encoder treating the trial record as premise. Baseline and KG-RAG conditions are paired and compared by Wilcoxon signed-rank test on the same NLI metrics. Human annotation (n=51) is used only for post-hoc correlation validation, not to define or fit the reported deltas. Hyperparameters (boost 0.15, top-10) are hand-chosen but do not make the observed entailment/faithfulness gains tautological. There are no self-definitional equations, no parameters fitted to the target metric and then re-presented as predictions, no load-bearing self-citations, and no uniqueness theorems or ansätze imported from the author’s prior work. The acknowledged weakness (NLI’s near-zero correlation with Unsupported Claims) is a validity/correctness issue, not circularity. The evaluation chain is therefore self-contained against external benchmarks.

Assumptions & free parameters 4 free parameters · 4 assumptions · 2 invented entities

The central claims rest on a small set of hand-chosen retrieval and scoring hyperparameters, standard domain assumptions that NLI is a usable proxy and that background abstracts do not contaminate the premise, and two author-defined constructs (the six-dimension schema and the hybrid retriever) that lack independent external validation beyond this paper.

free parameters (4)
  • PKG concept-grounding boost = 0.15
    Additive score boost of 0.15 applied to dense-similarity candidates whose PMIDs match PKG entities; chosen by hand with no reported ablation on the faithfulness metric.
  • retrieval candidate pool and top-k = 200 / 10
    200-candidate pool reduced to top-10 abstracts per trial; design choice without sensitivity analysis on NLI outcomes.
  • abstract text truncation = 1500 characters
    Each retrieved abstract truncated at 1,500 characters before prompt injection.
  • faithfulness_score entailment threshold = 0.5
    Sentence counted faithful if entailment probability exceeds 0.5; conventional but unvalidated for this clinical setting.
assumptions (4)
  • domain assumption Cross-encoder DeBERTa-v3-small NLI entailment is a valid scalable proxy for clinical summary faithfulness to the trial record
    Adopted as primary automated metric (§3.3); only weakly validated against 51 single-annotator pairs (composite r = +0.304).
  • ad hoc to paper The six-dimension ordinal schema and audience-specific prompts capture the clinically consequential faithfulness dimensions
    Defined by the authors, motivated by CONSORT 2010 and prior NLI work, but the specific 1–3 scoring rubric is original to this study (§3.2).
  • domain assumption Injected PubMed abstracts used only as background do not contaminate faithfulness-to-trial-record measurement when the trial record remains the NLI premise
    Explicit design choice in §3.4 required to interpret KG-RAG gains as improved fidelity to the source record.
  • domain assumption The stratified 200-trial sample (146 oncology / 34 mental health / 20 T2D) after quality filters is adequate for the reported conclusions
    Sampling procedure and seed stated in §3.1; generalizability beyond these three therapeutic areas is untested.
invented entities (2)
  • six-dimension faithfulness annotation schema (Factual Accuracy, Outcome Coverage, Risk and Safety Representation, Statistical Integrity, Unsupported Claims, Selective Reporting)
    purpose: Operationalize multi-audience clinical faithfulness on a 1–3 ordinal scale for both human annotation and correlation with NLI
    Author-defined construct; dimensions are motivated by CONSORT but the concrete rubric and aggregation are new and lack independent external validation.
  • hybrid PKG–PubMedBERT KG-RAG retriever for clinical-trial summarization
    purpose: Augment LLM prompts with trial-linked abstracts re-ranked by dense similarity plus a PKG entity boost
    Assembled from existing components (PKG2020S4, S-PubMedBert-MS-MARCO) but the hybrid design, retrieve-once-per-trial protocol, and application to multi-audience trial summarization are introduced here.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Faithful by Design: Evaluating and Improving LLM-Generated Clinical Trial Summaries for Multi-Stakeholder Audiences." pith.science (2026). https://pith.science/paper/UEF42IBY

@misc{pith2026260709932,
  author       = {Pith},
  title        = {Pith review of: Faithful by Design: Evaluating and Improving LLM-Generated Clinical Trial Summaries for Multi-Stakeholder Audiences},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/UEF42IBY}},
  note         = {Machine review of arXiv:2607.09932}
}
read the original abstract

Large language models are increasingly used to summarize clinical trial results for healthcare providers, patients, and payers, but their tendency to hallucinate poses significant risks in this high-stakes context. This study introduces a benchmark evaluation framework for measuring the faithfulness of LLM-generated clinical trial summaries across three stakeholder audiences. The framework consists of 200 stratified trials drawn from the Aggregate Analysis of ClinicalTrials.gov database, evaluated using audience-specific prompt templates and a six-dimension faithfulness annotation schema. Baseline measurements were established for GPT-4o, Claude Sonnet 4.6, and Gemini 2.5 Flash across 1,800 generated summaries scored using a cross-encoder natural language inference (NLI) model. Unsupported Claims was identified as the dominant failure mode across all three models, with a mean annotation score of 1.55 out of three. A knowledge-graph-augmented retrieval system was developed and evaluated against the baseline, producing statistically significant improvements in NLI-based faithfulness scores (entailment +0.0125, faithfulness +0.0130, p < 0.0001). Improvement pathways were model-dependent, with GPT-4o improving primarily through contradiction reduction while Claude Sonnet 4.6 and Gemini 2.5 Flash improved through increased entailment.

Figures

Figures reproduced from arXiv: 2607.09932 by the authors.

Figure 1
Figure 1. Benchmark composition by therapeutic area ( [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗
Figure 2
Figure 2. Overview of the complete evaluation pipeline, from [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗
Figure 5
Figure 5. Heatmap of mean faithfulness scores disaggregated [PITH_FULL_IMAGE:figures/full_fig_p005_5.png] view at source ↗
Figures from the paper (3 more)
Figure 6
Figure 6. Figure 6: Violin plots of entailment_mean score distributions for each model across 600 summaries per model. All three models show means well below 0.5 at baseline. 4.2 NLI Metric Validation [PITH_FULL_IMAGE:figures/full_fig_p005_6.png]
Figure 4
Figure 4. Figure 4: Radar chart of mean annotation scores by model [PITH_FULL_IMAGE:figures/full_fig_p005_4.png]
Figure 7
Figure 7. Figure 7: Spearman rank correlation matrix between NLI [PITH_FULL_IMAGE:figures/full_fig_p006_7.png]

Discussion (0). Sign in to comment.

Reference graph

Works this paper leans on

17 extracted references · 6 canonical work pages

  1. [1]

    Healey, Vittorio Loprinzo, Ulrike Kochendoerfer, Angela Russell Winnier, Peter V

    Rogier Landman, Sean P. Healey, Vittorio Loprinzo, Ulrike Kochendoerfer, Angela Russell Winnier, Peter V. Henstock, Wenyi Lin, Aqiu Chen, Arthi Rajendran, Sushant Penshanwar, Sheraz Khan, and Subha Madhavan. 2024. Using large language models for safety-related table summarization in clinical study reports. JAMIA Open7, 2 (2024), ooae043. https://doi.org/1...

    work page doi:10.1093/jamiaopen/ooae043 2024

  2. [2]

    Sewon Min, Kalpesh Krishna, Xinxi Lyu, Mike Lewis, Wen-tau Yih, Pang Wei Koh, Mohit Iyyer, Luke Zettlemoyer, and Hannaneh Hajishirzi. 2023. FActScore: Fine- Grained Atomic Evaluation of Factual Precision in Long Form Text Generation. InProceedings of the 2023 Conference on Empirical Methods in Natural Language Processing, pages 12076–12100. Association fo...

    2023

  3. [3]

    Elham Asgari, Nina Montaña-Brown, Magda Dubois, Saleh Khalil, Jasmine Bal- loch, Joshua Au Yeung, and Dominic Pimenta. 2025. A framework to assess clinical safety and hallucination rates of LLMs for medical text summarisation. npj Digital Medicine8, 274. https://doi.org/10.1038/s41746-025-01670-7

    doi:10.1038/s41746-025-01670-7 2025

  4. [4]

    Qi Jia, Siyu Ren, Yizhu Liu, and Kenny Q. Zhu. 2023. Zero-shot Faithfulness Evalu- ation for Text Summarization with Foundation Language Model. arXiv:2310.11648 [cs.CL]

    arXiv 2023

  5. [5]

    Huajian Zhang, Yumo Xu, and Laura Perez-Beltrachini. 2024. Fine-Grained Natu- ral Language Inference Based Faithfulness Evaluation for Diverse Summarisation Tasks. arXiv:2402.17630 [cs.CL]

    arXiv 2024

  6. [6]

    Pengcheng He, Xiaodong Liu, Jianfeng Gao, and Weizhu Chen. 2021. DeBERTa: Decoding-enhanced BERT with Disentangled Attention. InProceedings of the 9th International Conference on Learning Representations (ICLR 2021)

    2021

  7. [7]

    Rousseau, Xin Li, Weijia Xu, Vetle I

    Jian Xu, Sunkyu Kim, Min Song, Minbyul Jeong, Donghyeon Kim, Jaewoo Kang, Justin F. Rousseau, Xin Li, Weijia Xu, Vetle I. Torvik, Yi Bu, Chongyan Chen, Islam Akef Ebeid, Daifeng Li, and Ying Ding. 2020. Building a PubMed knowledge graph.Scientific Data7, 205. https://doi.org/10.1038/s41597-020-0543-2

    work page doi:10.1038/s41597-020-0543-2 2020

  8. [8]

    Christian Gulden, Melanie Kirchner, Christina Schüttler, Marc Hinderer, Marvin Kampf, Hans-Ulrich Prokosch, and Dennis Toddenroth. 2019. Extractive summa- rization of clinical trial descriptions.International Journal of Medical Informatics 129 (2019), 114–121. https://doi.org/10.1016/j.ijmedinf.2019.05.019

    work page doi:10.1016/j.ijmedinf.2019.05.019 2019

Show all 17 references
  1. [9]

    Lee, Sarah Bi, and Cassie S

    Irfan Al-Hussaini, Davi Nakajima An, Albert J. Lee, Sarah Bi, and Cassie S. Mitchell. 2022. CCS Explorer: Relevance Prediction, Extractive Summarization, and Named Entity Recognition from Clinical Cohort Studies. InProceedings of the 2022 IEEE International Conference on Big D...

    2022 doi

  2. [10]

    Rose, John H

    Karthik Soman, Peter W. Rose, John H. Morris, Rabia E. Akbas, Brett Smith, Braian Peetoom, Catalina Villouta-Reyes, Gabriel Cerono, Yongmei Shi, An- gela Rizk-Jackson, Sharat Israni, Charlotte A. Nelson, Sui Huang, and Sergio E. Baranzini. 2023. Biomedical knowledge graph-opti...

    2023 arXiv

  3. [11]

    Pouria Mortezaagha and Arya Rahgozar. 2026. Graph-Aware Late Chunking for Retrieval-Augmented Generation in Biomedical Literature. arXiv:2603.22633 [cs.AI]

    2026

  4. [12]

    McCourt, and Ricardo Pietrobon

    Asba Tasneem, Laura Aberle, Hari Ananth, Swati Chakraborty, Karen Chiswell, Brian J. McCourt, and Ricardo Pietrobon. 2012. The Database for Aggregate Analysis of ClinicalTrials.gov (AACT) and Subsequent Regrouping by Clinical Specialty.PLoS ONE7, 3 (2012), e33677. https://doi....

    2012 doi

  5. [13]

    National Center for Biotechnology Information. 2010. Entrez Programming Utilities Help [Internet]. National Center for Biotechnology Information (US), Bethesda (MD). https://www.ncbi.nlm.nih.gov/books/NBK25501/

    2010

  6. [14]

    Sascha Donner, Poroshista Knauer, Arne Kienzle, Jesse Dinneen, Joost Burger, Carsten Perka, and Stefanie Donner. 2025. Exploring Patient Perspectives, En- gagement, and Output Quality in Doctor-Supervised Use of Artificial Intelligence During Informed Consent Consultation With...

    2025 doi

  7. [15]

    Academy of Managed Care Pharmacy. 2024. AMCP Format for Formulary Submis- sions 5.0.Journal of Managed Care & Specialty Pharmacy30, 4-b (2024), S1–S261. https://doi.org/10.18553/jmcp.2024.30.4-b.s1

    2024 doi

  8. [16]

    Schulz, Douglas G

    Kenneth F. Schulz, Douglas G. Altman, and David Moher. 2010. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ340 (2010), c332. https://doi.org/10.1136/bmj.c332

    2010 doi

  9. [17]

    Yu Gu, Robert Tinn, Hao Cheng, Michael Lucas, Naoto Usuyama, Xiaodong Liu, Tristan Naumann, Jianfeng Gao, and Hoifung Poon. 2021. Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing.ACM Transactions on Computing for Healthcare3, 1, Article 2 (...

    2021 doi

Pith tools

Reviewed July 14, 2026 · model on record in the stance chip above.